Skip to main content

LCD L34424: Magnetic Resonance Angiography

LCD L34424, Magnetic Resonance Angiography, is the Local Coverage Determination that Palmetto GBA applies to claims from 7 states (AL, GA, NC, SC, TN, VA, WV), effective 2025-03-27 and first in force 2015-10-01. The policy text runs 216 words, and its billing and coding article A56775 lists 1,311 ICD-10-CM codes that support medical necessity for 24 procedure codes. 3 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 1,311 covered ICD-10-CM codes: 118 more codes than L33633 (Wellpoint Federal, 1,193 codes, revised 2026-04-01) and 312 more codes than L34865 (Novitas Solutions, Inc., 999 codes, revised 2020-07-01).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Palmetto GBA
States and territories
7
AL GA NC SC TN VA WV
Revision effective
2025-03-27
Original effective
2015-10-01
Policy text
216 words
Covered ICD-10 codes (articles)
1311

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34424
ContractContractorTypeStates
11201Palmetto GBAA and B and HHH MACSC
11301Palmetto GBAA and B and HHH MACVA
11401Palmetto GBAA and B and HHH MACWV
11501Palmetto GBAA and B and HHH MACNC
11202Palmetto GBAA and B and HHH MACSC
11302Palmetto GBAA and B and HHH MACVA
11402Palmetto GBAA and B and HHH MACWV
11502Palmetto GBAA and B and HHH MACNC
10111Palmetto GBAA and B MACAL
10211Palmetto GBAA and B MACGA
10311Palmetto GBAA and B MACTN
10112Palmetto GBAA and B MACAL
10212Palmetto GBAA and B MACGA
10312Palmetto GBAA and B MACTN

Billing and coding article A56775: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56775 (Billing and Coding: Magnetic Resonance Angiography) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56775: Billing and Coding: Magnetic Resonance Angiography (Billing and Coding, effective 2026-10-01)

Covered ICD-10-CM codes
1311
7 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
24
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56775
ICD-10-CMDescription (FY2027)
C49.A0Gastrointestinal stromal tumor, unspecified site
C49.A1Gastrointestinal stromal tumor of esophagus
C49.A2Gastrointestinal stromal tumor of stomach
C49.A3Gastrointestinal stromal tumor of small intestine
C49.A4Gastrointestinal stromal tumor of large intestine
C49.A5Gastrointestinal stromal tumor of rectum
C70.0Malignant neoplasm of cerebral meninges
C70.9Malignant neoplasm of meninges, unspecified
C71.0Malignant neoplasm of cerebrum, except lobes and ventricles
C71.1Malignant neoplasm of frontal lobe
C71.2Malignant neoplasm of temporal lobe
C71.3Malignant neoplasm of parietal lobe
C71.4Malignant neoplasm of occipital lobe
C71.5Malignant neoplasm of cerebral ventricle
C71.6Malignant neoplasm of cerebellum
C71.7Malignant neoplasm of brain stem
C71.8Malignant neoplasm of overlapping sites of brain
C71.9Malignant neoplasm of brain, unspecified
C75.4Malignant neoplasm of carotid body
C75.5Malignant neoplasm of aortic body and other paraganglia
C79.31Secondary malignant neoplasm of brain
C79.32Secondary malignant neoplasm of cerebral meninges
C79.40Secondary malignant neoplasm of unspecified part of nervous system
C79.49Secondary malignant neoplasm of other parts of nervous system

Procedure codes: 70544, 70545, 70546, 70547, 70548, 70549, C8900 (Magnetic resonance angiography with contrast, abdomen), C8901 (Magnetic resonance angiography without contrast, abdomen), C8902 (Magnetic resonance angiography without contrast followed by with contrast, abdomen), C8909 (Magnetic resonance angiography with contrast, chest (excluding myocardium)), C8910 (Magnetic resonance angiography without contrast, chest (excluding myocardium)), C8911 (Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)), C8912 (Magnetic resonance angiography with contrast, lower extremity), C8913 (Magnetic resonance angiography without contrast, lower extremity), C8914 (Magnetic resonance angiography without contrast followed by with contrast, lower extremity), C8918 (Magnetic resonance angiography with contrast, pelvis), C8919 (Magnetic resonance angiography without contrast, pelvis), C8920 (Magnetic resonance angiography without contrast followed by with contrast, pelvis), C8931 (Magnetic resonance angiography with contrast, spinal canal and contents), C8932 (Magnetic resonance angiography without contrast, spinal canal and contents), C8933 (Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents), C8934 (Magnetic resonance angiography with contrast, upper extremity), C8935 (Magnetic resonance angiography without contrast, upper extremity), C8936 (Magnetic resonance angiography without contrast followed by with contrast, upper extremity).

Coverage indications, limitations and medical necessity

Magnetic resonance angiography (MRA) is a modern diagnostic technique based on the effect of nuclear magnetic resonance and is like magnetic resonance imaging (MRI). During the procedure, the device reads electromagnetic waves received during the oscillation of the nuclei of hydrogen atoms, after which the computer converts the information received into a three-dimensional image of the zone under study. MRA is utilized to carry out studies of arteries, veins and lymphatic vessels of any location, to carry out a detailed assessment of the state of vascular networks, to identify pathological changes in the early stages, and to determine the cause of the pathology. 1

The coverage criteria and definition of MRA are found in the CMS Internet-only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §220.2. MRA with or without contrast is considered appropriate when it can replace a more invasive test (e.g., contrast angiography) and reduce risk for beneficiaries. MRA is a covered indication for various diseases and abnormalities involving the arterial, venous and lymphatic systems. In addition, the services must be reasonable and necessary for the diagnosis or treatment of the specific patient involved.

The use of MRA would have the same contraindications as MRI and should not be used in patients with implanted ferromagnetic structures and electronic devices.

Summary of evidence (opening)

MRA encompasses several imaging techniques based on MRI developed for studying the arterial and venous systems. The benefits of an MRA in comparison to traditional angiography is that it is noninvasive, it lacks ionizing radiation exposure, it has the potential for a non-contrast examination, and it can produce high-resolution volumetric images. The MRA gadolinium contrast material is less likely to cause an allergic reaction than the iodine-based contrast materials used for computed tomography scanning.

An MRA is often indicated to evaluate the following abnormalities and conditions and is used for screening 1 and monitoring purposes 1 : arterial aneurysm(s) 1 , arteriovenous malformations 2-4 , aortic coarctation 1 , aortic dissection 5,6 , cerebral stroke 1 , carotid artery disease 7,8 , peripheral atherosclerosis of the extremities 1 , congenital heart disease 1 , coronary artery disease and, if indicated, graft patency 9-12 , mesentery artery ischemia 13,14 , renal artery stenosis 15 , pulmonary embolism 16,17 , trigeminal neuralgia 18-20 , moyamoya disease 21,22 and intracranial aneurysms. 23,24

MRA has the same contraindications as MRI, including patients with implanted ferromagnetic structures and electronic devices. Such devices might include, but are not limited to the following: a cardiac implantable electronic device, mechanical metallic heart valves, metallic foreign bodies, implantable neurostimulation system, cochlear implants/ear implant, non-removable drug infusion pumps, catheters with metallic components, cerebral artery aneurysm clips which are non-MRI compatible, and tissue expanders with magnetic infusion ports. 25 Other contraindications for use of the contrast medium include a previous allergic or anaphylactic reaction to gadolinium. 26

The contractor cites 27 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2025-03-27
Last reviewed by the contractor
2024-10-29
MCD version
47
Derived from
L31590

The contractor lists one National Coverage Determination as related: NCD 220.2 Magnetic Resonance Imaging. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Other related documents: A59946 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Palmetto GBA hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34424 cover?

Magnetic resonance angiography (MRA) is a modern diagnostic technique based on the effect of nuclear magnetic resonance and is like magnetic resonance imaging (MRI). During the procedure, the device reads electromagnetic waves received during the oscillation of the nuclei of hydrogen atoms, after which the computer converts the information received into a three-dimensional image of the zone under study. MRA is… The full 216-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34424 apply to?

Palmetto GBA applies it to Medicare claims in 7 states: AL, GA, NC, SC, TN, VA, WV. It binds only that contractor; 3 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34424?

The companion billing and coding article A56775 lists 1,311 ICD-10-CM codes in 7 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34424?

A denial under LCD L34424 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56775's 1,311 covered diagnosis codes, then file a redetermination with Palmetto GBA within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.